Medication‐related problems in chronic inflammatory conditions: A pharmacy claims and electronic health record analysis-Reference-Cited by-同舟云学术

Medication‐related problems in chronic inflammatory conditions: A pharmacy claims and electronic health record analysis

Published:2021-03-16 Issue:5 Volume:4 Page:570-579
ISSN:2574-9870
Container-title:JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY
language:en
Short-container-title:J Am Coll Clin Pharm

Author:

Chang Susan¹²^ORCID,Stebbins Marilyn¹,Witt Edward A.³,Kirkham Heather³,Santos Troy¹,Cocohoba Jennifer¹^ORCID

Affiliation:

1. University of California San Francisco School of Pharmacy San Francisco California USA

2. Global Access & Health Economics Roche Molecular Systems Pleasanton California USA

3. Health Analytics, Research, and Reporting, Walgreen Co Deerfield Illinois USA

Funder

Walgreens

Publisher

Wiley

Subject

Pharmacology (medical),Pharmaceutical Science,Pharmacy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jac5.1417

Reference26 articles.

1. Adalimumab in the Treatment of Immune-Mediated Diseases

2. The role of specialty pharmacy drugs in the management of inflammatory diseases

3. National Association of Specialty Pharmacy. NASP Definitions of Specialty Pharmacy and Specialty Medications 12/5/2020. Available fromhttps://naspnet.org/wp-content/uploads/2017/02/NASP-Defintions-final-2.16.pdf.

4. BryneM. The Ins and Outs of Specialty Pharmacy 12/2/2020. Available fromhttps://www.pharmacytimes.com/news/the-ins-and-outs-of-specialty-pharmacy.

5. IQVIA.The Global Use of Medicine in 2019 and Outlook to 2023: Forecasts and Areas to Watch 6/20/2020. Available fromhttps://www.iqvia.com/insights/the-iqvia-institute/reports/the-global-use-of-medicine-in-2019-and-outlook-to-2023.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Use of the BRANT-MERQS scoring table for the quality assessment of type 3 medication review in patients with rheumatoid arthritis and those with type 2 diabetes mellitus;Frontiers in Pharmacology;2024-08-16

2. What Do We Know about Medication Adherence Interventions in Inflammatory Bowel Disease, Multiple Sclerosis and Rheumatoid Arthritis? A Scoping Review of Randomised Controlled Trials;Patient Preference and Adherence;2023-12